Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Nachman

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
The New England Journal of Medicine|July 8, 2011
Primary isoniazid prophylaxis against tuberculosis in HIV-exposed childrenShabir A Madhi, Sharon Nachman, Avy Violari, et al.
Pediatrics|July 15, 2009
Mental health treatment patterns in perinatally HIV-infected youth and controlsMiriam Chernoff, Sharon Nachman, Paige Williams, et al.
AIDS Research and Human Retroviruses|September 13, 2016
Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving RaltegravirFlorin Tuluc, Sergei Spitsin, Nancy B Tustin, et al.
AIDS (London, England)|December 20, 2007
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected childrenAkihiko Saitoh, Elizabeth Sarles, Edmund Capparelli, et al.
Journal of the Pediatric Infectious Diseases Society|December 1, 2015
Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C StudyJohn S Schieffelin, Paige L Williams, Divna Djokic, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403Jennifer R King, Sharon Nachman, Ram Yogev, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2019
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingJos Lommerse, Diana Clarke, Thomas Kerbusch, et al.
Pediatrics|April 3, 2002
Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infectionRussell B Van Dyke, Sophia Lee, George M Johnson, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|January 30, 2010
Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sampleKenneth D Gadow, Miriam Chernoff, Paige L Williams, et al.
Pediatrics|March 3, 2006
A behavioral and cognitive profile of clinically stable HIV-infected childrenMolly L Nozyce, Sophia S Lee, Andrew Wiznia, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
The New England Journal of Medicine|July 8, 2011
Primary isoniazid prophylaxis against tuberculosis in HIV-exposed childrenShabir A Madhi, Sharon Nachman, Avy Violari, et al.
Pediatrics|July 15, 2009
Mental health treatment patterns in perinatally HIV-infected youth and controlsMiriam Chernoff, Sharon Nachman, Paige Williams, et al.
AIDS Research and Human Retroviruses|September 13, 2016
Decreased PD-1 Expression on CD8 Lymphocyte Subsets and Increase in CD8 Tscm Cells in Children with HIV Receiving RaltegravirFlorin Tuluc, Sergei Spitsin, Nancy B Tustin, et al.
AIDS (London, England)|December 20, 2007
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected childrenAkihiko Saitoh, Elizabeth Sarles, Edmund Capparelli, et al.
Journal of the Pediatric Infectious Diseases Society|December 1, 2015
Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C StudyJohn S Schieffelin, Paige L Williams, Divna Djokic, et al.
The Pediatric Infectious Disease Journal|October 13, 2005
Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: pediatric AIDS clinical trials group protocol 403Jennifer R King, Sharon Nachman, Ram Yogev, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2019
Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal DosingJos Lommerse, Diana Clarke, Thomas Kerbusch, et al.
Pediatrics|April 3, 2002
Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infectionRussell B Van Dyke, Sophia Lee, George M Johnson, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|January 30, 2010
Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sampleKenneth D Gadow, Miriam Chernoff, Paige L Williams, et al.
Pediatrics|March 3, 2006
A behavioral and cognitive profile of clinically stable HIV-infected childrenMolly L Nozyce, Sophia S Lee, Andrew Wiznia, et al.
Pageof 11